TrialCell reports. Medicine2022
LEAP2 reduces postprandial glucose excursions and
Christoffer A Hagemann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this papertrialcites it
TrialCell reports. Medicine2022
Christoffer A Hagemann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.